Insulet | PODD - Ebitda

金融业

USD 149.68

USD 3.17B

现金及等价物

USD 534.9M

USD 239.1M

USD 1.85B

USD 744.2M

USD 948.4M

USD 129.7M

USD 199.8M

3.9K

EPS每股收益

USD 1.66

股本和储备

USD 1.42B

USD 562.6M

债务利息支出

USD 11M

USD 4.9M

USD 929.5M

USD 10.47B

USD 95M

USD 672M

USD 129.7M

普通股股本

USD 69.35M

29.66

USD 118.7M

USD 801.7M

销售和管理费用

USD 344.8M

USD 484.8M

贸易债权人

USD 123.3M

应收帐款人

USD 588.7M

	Ebitda	更改		日
Abbott	USD 2.43B		844M	2026-03
Align Technology	USD 232.86M		3.72M	2026-06
AtriCure	USD 27.28M		10.21M	2026-06
Baxter International	USD 474M		165M	2026-06
Becton, Dickinson and Co.	USD 1.71B		1B	2026-06
Boston Scientific	USD 1.63B		27M	2026-06
Cardinal Health	USD 955M		135M	2026-06
Cooper Companies	USD 67.9M		255.5M	2026-03
Dexcom	USD 435.2M		46.5M	2026-09
Edwards Lifesciences	USD 555.6M		485.5M	2026-03
Eli Lilly	USD 9.46B		3.54B	2026-09
Globus Medical	USD 279.84M		48.01M	2026-06
ICU Medical	USD 110.03M		11.35M	2026-06
Insulet	USD 199.8M		18.1M	2026-06
Integra LifeSciences	USD 79.79M		1.37M	2026-09
J&J	USD 8.99B		721M	2026-06
Medtronic	USD 2.63B		174M	2026-06
Merit Medical Systems	USD 103.93M		461K	2026-09
Roche Holding	CHF 13.43B		744M	2026-06
Solventum Corp	USD 670M		233M	2026-06
Stryker	USD 1.83B		102M	2026-09
Tandem Diabetes Care	USD 6.42M		3.69M	2026-06
Teleflex	USD 122.91M		47.28M	2026-06
West Pharmaceutical Services	USD 267.4M		23.8M	2026-09
Zimmer Biomet Holdings	USD 830.5M		190.4M	2026-06